CorMedix (CRMD) Return on Assets (2016 - 2025)
CorMedix (CRMD) has disclosed Return on Assets for 12 consecutive years, with 0.21% as the latest value for Q4 2025.
- Quarterly Return on Assets rose 20.0% to 0.21% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.21% through Dec 2025, up 20.0% year-over-year, with the annual reading at 0.35% for FY2025, N/A changed from the prior year.
- Return on Assets hit 0.21% in Q4 2025 for CorMedix, down from 0.36% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.36% in Q3 2025 to a low of 0.79% in Q2 2024.
- Historically, Return on Assets has averaged 0.32% across 5 years, with a median of 0.45% in 2021.
- Biggest five-year swings in Return on Assets: decreased -15bps in 2024 and later surged 114bps in 2025.
- Year by year, Return on Assets stood at 0.42% in 2021, then decreased by -15bps to 0.48% in 2022, then dropped by -12bps to 0.54% in 2023, then skyrocketed by 102bps to 0.01% in 2024, then surged by 1688bps to 0.21% in 2025.
- Business Quant data shows Return on Assets for CRMD at 0.21% in Q4 2025, 0.36% in Q3 2025, and 0.35% in Q2 2025.